Explore the latest advancements in CAR T-Cell Therapy and its potential applications for Scleroderma treatment in this informative patient forum video. Delve into historical work on immunological reset for treatment resistance, B cell depletion therapy, and CAR T therapy. Discover the use of engineered natural killer cells targeting CD19 and precision immunotherapies. Gain insights from expert presentations by Dr. Peter Merkel, Dr. Max Konig, Dr. Peter Maag, and Dr. David Shook, covering various aspects of this cutting-edge research. Originally presented as part of the 3rd annual SRF Patient Forum, "Collaborating for a Cure," this comprehensive session offers valuable information for patients, caregivers, and healthcare professionals interested in the future of Scleroderma treatment.
CAR T-Cell Therapy and Scleroderma - Today and Future - 2024
Overview
Syllabus
Patient Forum: CAR T-Cell Therapy & Scleroderma – Today and Future (2024)
Taught by
SRFCURE
Related Courses
-
Scleroderma and Cancer: Implications for Cancer Screening and Therapy - 2024
-
CAR T-Cell Therapy in Systemic Sclerosis - Clinical Trials and Potential Benefits
-
CAR T at UCLA - Driving the Progress of Engineered Cell Therapy
-
CAR T-Cell Therapy for Pediatric Cancer - Satiro de Oliveira, MD - UCLAMDChat
-
Quantifying CAR T Cells Activity Against AML - Model Selection Based on In Vitro Cytolytic Assays
-
A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer
